Annual Income Tax
$20.92 M
+$12.90 M+160.99%
31 December 2023
Summary:
BioMarin Pharmaceutical annual income tax is currently $20.92 million, with the most recent change of +$12.90 million (+160.99%) on 31 December 2023. During the last 3 years, it has risen by +$923.94 million (+102.32%). BMRN annual income tax is now -74.23% below its all-time high of $81.17 million, reached on 31 December 2017.BMRN Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Income Tax
$28.36 M
+$3.40 M+13.62%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly income tax is currently $28.36 million, with the most recent change of +$3.40 million (+13.62%) on 30 September 2024. Over the past year, it has increased by +$27.07 million (+2096.82%). BMRN quarterly income tax is now -73.24% below its all-time high of $105.99 million, reached on 31 December 2017.BMRN Quarterly Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Income Tax
$69.16 M
+$27.07 M+64.31%
30 September 2024
Summary:
BioMarin Pharmaceutical TTM income tax is currently $69.16 million, with the most recent change of +$27.07 million (+64.31%) on 30 September 2024. Over the past year, it has increased by +$64.50 million (+1385.08%). BMRN TTM income tax is now -16.20% below its all-time high of $82.53 million, reached on 31 March 2018.BMRN TTM Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Income Tax Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +161.0% | +2096.8% | +1385.1% |
| 3 y3 years | +102.3% | +393.4% | +204.0% |
| 5 y5 years | +131.9% | +162.7% | +180.6% |
BMRN Income Tax High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +102.3% | at high | +263.9% | at high | +204.0% |
| 5 y | 5 years | at high | +102.3% | at high | +103.3% | at high | +107.5% |
| alltime | all time | -74.2% | +102.3% | -73.2% | +103.3% | -16.2% | +107.5% |
BioMarin Pharmaceutical Income Tax History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $28.36 M(+13.6%) | $69.16 M(+64.3%) |
| June 2024 | - | $24.96 M(+47.8%) | $42.09 M(+32.0%) |
| Mar 2024 | - | $16.89 M(-1711.2%) | $31.90 M(+52.5%) |
| Dec 2023 | $20.92 M(+161.0%) | -$1.05 M(-181.2%) | $20.92 M(+349.2%) |
| Sept 2023 | - | $1.29 M(-91.3%) | $4.66 M(-42.6%) |
| June 2023 | - | $14.77 M(+150.1%) | $8.11 M(+1428.1%) |
| Mar 2023 | - | $5.91 M(-134.1%) | $531.00 K(-93.4%) |
| Dec 2022 | $8.02 M(-171.1%) | -$17.31 M(-464.6%) | $8.02 M(-51.9%) |
| Sept 2022 | - | $4.75 M(-33.9%) | $16.65 M(+645.2%) |
| June 2022 | - | $7.19 M(-46.3%) | $2.23 M(-159.8%) |
| Mar 2022 | - | $13.39 M(-254.3%) | -$3.74 M(-66.8%) |
| Dec 2021 | -$11.27 M(-98.8%) | -$8.68 M(-10.2%) | -$11.27 M(-83.0%) |
| Sept 2021 | - | -$9.67 M(-895.6%) | -$66.48 M(-92.6%) |
| June 2021 | - | $1.22 M(-79.3%) | -$902.84 M(-1.6%) |
| Mar 2021 | - | $5.86 M(-109.2%) | -$917.14 M(+1.6%) |
| Dec 2020 | -$903.03 M(+1172.5%) | -$63.89 M(-92.4%) | -$903.03 M(+4.5%) |
| Sept 2020 | - | -$846.02 M(+6363.1%) | -$863.94 M(+1268.3%) |
| June 2020 | - | -$13.09 M(-165.5%) | -$63.14 M(+15.8%) |
| Mar 2020 | - | $19.97 M(-180.5%) | -$54.51 M(-23.2%) |
| Dec 2019 | -$70.96 M(+8.4%) | -$24.80 M(-45.1%) | -$70.96 M(-17.3%) |
| Sept 2019 | - | -$45.21 M(+913.8%) | -$85.82 M(+81.1%) |
| June 2019 | - | -$4.46 M(-226.8%) | -$47.40 M(-14.3%) |
| Mar 2019 | - | $3.52 M(-108.9%) | -$55.32 M(-15.5%) |
| Dec 2018 | -$65.49 M(-180.7%) | -$39.66 M(+483.9%) | -$65.49 M(-181.7%) |
| Sept 2018 | - | -$6.79 M(-45.2%) | $80.16 M(+1.6%) |
| June 2018 | - | -$12.38 M(+86.1%) | $78.86 M(-4.4%) |
| Mar 2018 | - | -$6.66 M(-106.3%) | $82.53 M(+1.7%) |
| Dec 2017 | $81.17 M(-140.4%) | $105.99 M(-1409.5%) | $81.17 M(-409.0%) |
| Sept 2017 | - | -$8.09 M(-7.1%) | -$26.27 M(-44.8%) |
| June 2017 | - | -$8.71 M(+8.7%) | -$47.56 M(-76.5%) |
| Mar 2017 | - | -$8.02 M(+454.4%) | -$202.78 M(+1.0%) |
| Dec 2016 | -$200.84 M(-1276.2%) | -$1.45 M(-95.1%) | -$200.84 M(+14.7%) |
| Sept 2016 | - | -$29.39 M(-82.1%) | -$175.05 M(+20.6%) |
| June 2016 | - | -$163.93 M(+2598.5%) | -$145.18 M(-897.6%) |
| Mar 2016 | - | -$6.08 M(-125.0%) | $18.20 M(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $17.07 M(+87.6%) | $24.35 M(+4941.0%) | $17.07 M(-631.4%) |
| Sept 2015 | - | $483.00 K(-187.2%) | -$3.21 M(-59.4%) |
| June 2015 | - | -$554.00 K(-92.3%) | -$7.92 M(+397.5%) |
| Mar 2015 | - | -$7.20 M(-277.4%) | -$1.59 M(-117.5%) |
| Dec 2014 | $9.10 M(-6167.3%) | $4.06 M(-196.1%) | $9.10 M(+18.9%) |
| Sept 2014 | - | -$4.22 M(-173.2%) | $7.66 M(-39.2%) |
| June 2014 | - | $5.77 M(+65.4%) | $12.58 M(+56.3%) |
| Mar 2014 | - | $3.49 M(+33.5%) | $8.05 M(-5468.0%) |
| Dec 2013 | -$150.00 K(-96.2%) | $2.62 M(+271.4%) | -$150.00 K(-198.0%) |
| Sept 2013 | - | $704.00 K(-43.3%) | $153.00 K(-102.2%) |
| June 2013 | - | $1.24 M(-126.4%) | -$6.96 M(-19.2%) |
| Mar 2013 | - | -$4.71 M(-261.4%) | -$8.61 M(+119.0%) |
| Dec 2012 | -$3.93 M(-138.5%) | $2.92 M(-145.6%) | -$3.93 M(+21.7%) |
| Sept 2012 | - | -$6.40 M(+1458.2%) | -$3.23 M(-394.7%) |
| June 2012 | - | -$411.00 K(+1108.8%) | $1.10 M(-79.7%) |
| Mar 2012 | - | -$34.00 K(-100.9%) | $5.41 M(-47.0%) |
| Dec 2011 | $10.21 M(-104.5%) | $3.62 M(-274.2%) | $10.21 M(-2324.2%) |
| Sept 2011 | - | -$2.08 M(-153.2%) | -$459.00 K(-99.8%) |
| June 2011 | - | $3.90 M(-18.1%) | -$220.33 M(-1.3%) |
| Mar 2011 | - | $4.76 M(-167.6%) | -$223.18 M(-1.8%) |
| Dec 2010 | -$227.31 M(<-9900.0%) | -$7.05 M(-96.8%) | -$227.31 M(+2.8%) |
| Sept 2010 | - | -$221.95 M(<-9900.0%) | -$221.09 M(<-9900.0%) |
| June 2010 | - | $1.06 M(+66.0%) | $1.81 M(+41.9%) |
| Mar 2010 | - | $636.00 K(-176.6%) | $1.27 M(+20.8%) |
| Dec 2009 | $1.05 M(-59.4%) | -$830.00 K(-187.8%) | $1.05 M(-73.2%) |
| Sept 2009 | - | $945.00 K(+81.0%) | $3.93 M(+21.4%) |
| June 2009 | - | $522.00 K(+25.2%) | $3.24 M(+12.8%) |
| Mar 2009 | - | $417.00 K(-79.7%) | $2.87 M(+10.8%) |
| Dec 2008 | $2.59 M(+255.7%) | $2.05 M(+713.5%) | $2.59 M(+270.4%) |
| Sept 2008 | - | $252.00 K(+64.7%) | $700.00 K(+9.4%) |
| June 2008 | - | $153.00 K(+10.9%) | $640.00 K(+31.4%) |
| Mar 2008 | - | $138.00 K(-12.1%) | $487.00 K(+29.9%) |
| Dec 2007 | $729.00 K | $157.00 K(-18.2%) | $375.00 K(+72.0%) |
| Sept 2007 | - | $192.00 K(+638.5%) | $218.00 K(+738.5%) |
| Mar 2007 | - | $26.00 K | $26.00 K |
FAQ
- What is BioMarin Pharmaceutical annual income tax?
- What is the all time high annual income tax for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual income tax year-on-year change?
- What is BioMarin Pharmaceutical quarterly income tax?
- What is the all time high quarterly income tax for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly income tax year-on-year change?
- What is BioMarin Pharmaceutical TTM income tax?
- What is the all time high TTM income tax for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM income tax year-on-year change?
What is BioMarin Pharmaceutical annual income tax?
The current annual income tax of BMRN is $20.92 M
What is the all time high annual income tax for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual income tax is $81.17 M
What is BioMarin Pharmaceutical annual income tax year-on-year change?
Over the past year, BMRN annual income tax has changed by +$12.90 M (+160.99%)
What is BioMarin Pharmaceutical quarterly income tax?
The current quarterly income tax of BMRN is $28.36 M
What is the all time high quarterly income tax for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly income tax is $105.99 M
What is BioMarin Pharmaceutical quarterly income tax year-on-year change?
Over the past year, BMRN quarterly income tax has changed by +$27.07 M (+2096.82%)
What is BioMarin Pharmaceutical TTM income tax?
The current TTM income tax of BMRN is $69.16 M
What is the all time high TTM income tax for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM income tax is $82.53 M
What is BioMarin Pharmaceutical TTM income tax year-on-year change?
Over the past year, BMRN TTM income tax has changed by +$64.50 M (+1385.08%)